Zeno Pharmaceuticals, Inc. — Form D/A
Zeno Pharmaceuticals, Inc. of San Diego, CA, a company, filed a Form D amendment with the SEC on 2016-03-16. The offering totals $18.3M, of which $18.3M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2016-03-16
- Form: D/A
- Accession: 0001140361-16-057882
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $18.3M
- Amount sold: $18.3M
- Investors: 11
- Date of first sale: 2015-09-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-248004
Issuer
- Name: Zeno Pharmaceuticals, Inc.
- CIK: 0001653424
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 10835 Road to the Cure, #205, San Diego, CA, 92121
- Phone: (858) 263-4333
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Cam Y Gallagher | Director | San Diego, CA |
| Anthony Y Sun | Director | NEW YORK, NY |
| Cam Y Gallagher | Executive Officer | San Diego, CA |
| Anthony Y Sun | Executive Officer | NEW YORK, NY |
Other filings by this issuer (1)
More